Duloxetine
Cymbalta, DRIZALMA SPRINKLE, DULOXETINE, DULOXETINE HYDROCHLORIDE
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
NADAC/unit
$0.0848
No Shortage
Tier 1: 162.9%
PA Req: 144.4%
16 Manufacturers
52 ANDAs
Duloxetine delayed-release capsules is indicated for the treatment of: Major depressive disorder in adults Generalized anxiety disorder in adults and pediatric patients 7 years of age and older Dia....
vs. brand Cymbalta: Generic saves up to 99% per unit
Market Intelligence
2025-12-10 Class II Recall: Breckenridge Pharmaceutical, Inc.
2025-12-10 Class II Recall: Breckenridge Pharmaceutical, Inc.
2025-11-05 Class II Recall: Breckenridge Pharmaceutical, Inc.
2025-09-17 Class II Recall: Breckenridge Pharmaceutical, Inc.
2025-08-20 Class II Recall: Breckenridge Pharmaceutical, Inc.
Generic Manufacturers
ACTAVIS ELIZABETH LLCAJANTA PHARMA LTDALEMBIC PHARMACEUTICALS LTDALKEM LABORATORIES LTDALMATICA PHARMA LLCAUROBINDO PHARMA LTDBRECKENRIDGE PHARMACEUTICAL INCCSPC OUYI PHARMACEUTICAL CO LTDHETERO LABS LTD UNIT IIIINVENTIA HEALTHCARE LTDLUPIN LTDMACLEODS PHARMACEUTICALS LTDPRINSTON PHARMACEUTICAL INCQINGDAO BAHEAL PHARMACEUTICAL CO LTDSUN PHARMACEUTICAL INDUSTRIES LTDSUNSHINE LAKE PHARMA CO LTDZYDUS HEALTHCARE USA LLCZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.